Immunotherapy of antigen-presenting autologous dendrite cells in the complex treatment of patients with cerebral hemisphere malignant gliomas
The aim of the research is to investigate activation of antitumor immune response efficiency using professional antigen-presenting autologous dendrite cells in the complex treatment of patients with cerebral hemisphere malignant gliomas. We have analysed 48 cases of patients with malignant gliomas (...
Main Authors: | S. P. Bajanov, V. Ye. Olyushin, M. V. Filatov, A. Yu. Ulitin |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2008-12-01
|
Series: | Bûlleten' Sibirskoj Mediciny |
Online Access: | https://bulletin.tomsk.ru/jour/article/view/3436 |
Similar Items
-
Recent Advances of Dendritic Cells (DCs)-Based Immunotherapy for Malignant Gliomas
by: Der-Yang Cho, et al.
Published: (2009-09-01) -
319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine
by: Gabriel Nistor, et al.
Published: (2020-11-01) -
The results of combined immunotherapy in integrated treatment of patients with malignant brain glioma
by: V. V. Stupak, et al.
Published: (2008-12-01) -
Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma
by: Niken M. Mahaweni, et al.
Published: (2013-10-01) -
Prediction of treatment results of low-grade gliomas of the cerebral hemispheres.
by: A. G. Sirko, et al.
Published: (2017-10-01)